78.53
+3.29%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Camlin Fine Sciences
Its shares trade on NSE under the ticker CAMLINFINE.NS. It has been listed since 20 January 2015. In the fiscal year to 31 March 2026, it reported revenue of ₹17.23bn and net income of ₹276.3m. At that date it held total assets of ₹23.24bn and shareholders' equity of ₹10.41bn.
Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2015-01-20. The firm is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The firm manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 20 Jan 2015
- Employees
- 627
- Website
- camlinfs.com ↗
Leadership
Pay as last reported
- Mr. Ashish DandekarChairman of the Board, Managing Director, since 2021₹19.7m
- Mr. Santosh ParabChief Financial Officer
- Mr. Nilesh JadhavChief Operating Officer
- Mr. Rahul SawaleChief Compliance Officer, Vice President - Legal, Company Secretary₹700,000
- Mr. Nirmal MomayaManaging Director, since 2014₹16.8m
- Mr. Arjun DukaneExecutive Director - Technical, since 2018₹9.7m
- Ms. Anagha DandekarNon-Executive Non-Independent Director₹500,000
- Mr. Jens NieuwenborghNon-Executive Non-Independent Director
- Mr. Harsha RaghavanNon-Executive Non-Independent Director
- Mr. Joseph DsouzaNon-Executive Independent Director₹1.1m
- Ms. Radhika DudhatAdditional Non-Executive Independent Director
- Mr. Abeezar FaizullabhoyAdditional Non-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Camlin Fine Sciences Ltd. employs 627 full-time employees in Mumbai, Maharashtra.
- The company offers diverse advanced antioxidants and shelf-life extensions globally.
- Camlin Fine Sciences Ltd. provides aroma ingredients and performance chemical products for multiple industries.
Weaknesses
- The company's products include TBHQ, Catechol, BHA, and 4-Tertiary Butyl Catechol.
- Camlin Fine Sciences Ltd. manufactures specialty chemicals for food, animal nutrition, and pet food.
- The firm's product portfolio features NaSure, MEHQ, Ascorbyl Palmitate, and HQEE.
Opportunities
- Camlin Fine Sciences Ltd. serves the global petrochemical industry with its chemical solutions.
- The company targets the pharmaceutical and nutraceutical sectors for growth opportunities.
- Camlin Fine Sciences Ltd. provides health and wellness solutions for the health care industry.
Threats
- The company's business is limited to the Materials sector in the Chemicals industry.
- Camlin Fine Sciences Ltd. operates within the Indian market with a focus on Mumbai.
- The firm's IPO listing date of 20 January 2015 may affect its market position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.